We have developed a model to accurately quantify the signals produced by exogenous scattering agents used for contrast-enhanced Optical Coherence Tomography (OCT). This model predicts distinct concentration-dependent signal trends that arise from the underlying physics of OCT detection. Accordingly, we show that real scattering particles can be described as simplified ideal scatterers with modified scattering intensity and concentration. The relation between OCT signal and particle concentration is approximately linear at concentrations lower than 0.8 particle per imaging voxel. However, at higher concentrations, interference effects cause signal to increase with a square root dependence on the number of particles within a voxel. Finally, high particle concentrations cause enough light attenuation to saturate the detected signal. Predictions were validated by comparison with measured OCT signals from gold nanorods (GNRs) prepared in water at concentrations ranging over five orders of magnitude (50 fM to 5 nM). In addition, we validated that our model accurately predicts the signal responses of GNRs in highly heterogeneous scattering environments including whole blood and living animals. By enabling particle quantification, this work provides a valuable tool for current and future contrast-enhanced in vivo OCT studies. More generally, the model described herein may inform the interpretation of detected signals in modalities that rely on coherence-based detection or are susceptible to interference effects. V C 2016 AIP Publishing LLC.
[http://dx.doi.org/10.1063/1.4939547] Optical Coherence Tomography (OCT) uses low coherence interferometry to obtain micron-resolution images of scattering samples. 1 While OCT has long been used for structural studies, it has only recently been explored for contrast-enhanced molecular imaging. [2] [3] [4] However, for such contrast-enhanced OCT studies to reach their full potential, quantitative imaging capabilities during in vivo experiments are needed in order to assess biomarker expression levels, 5 disease response to therapy, 6 and developmental processes. Thus, the ability to easily extract quantitative information about scattering contrast agents will be useful for realizing OCT as a molecular modality. However, accurate quantitative measurements are not readily obtained from OCT images since detected signals comprise convoluted information from single and multiple scattering events as well as interference among photons within a given imaging volume. 8, 9 These effects impede quantification, especially in nonuniform scattering media such as biological tissues.
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Studies have previously modeled scattering in tissue phantoms using the independent scattering approximation, which yields signal linearity with concentration. 11 However, these models are only valid for low scatterer concentrations. 12, 13 Other work has assumed signal with a polynomial dependence on scatterer concentration. 14 More recently, Mie theory and the extended Huygens-Fresnel (EHF) model have been used to model scattering. [15] [16] [17] [18] These models have enabled quantification of tissue optical properties and highlight the non-linearity of OCT signal with increasing scatterer concentration. However, these models require the adjustment of many parameters and are limited in fundamental physical scope by the assumptions of Mie scattering. In addition, models of the signal properties of OCT contrast agents, particularly in biological tissues, have not yet been established.
Here, we report the development of a physical model to predict the OCT signal detected from nanoscale scattering particles. Unlike Mie and EHF models, our model assumes ray scattering principles and requires no a priori knowledge of particle-specific parameters or dominating physical scattering mechanisms. Therefore, the model is generally applicable to particles of any morphology and heterogeneous scattering environments. Using this approach, we accurately predicted concentration-dependent trends in the OCT signal from gold nanorods (GNRs) prepared in water, whole blood and injected intravenously into living mice.
We start with the highly simplified assumptions that (1) all particles within a sample reflect the same amount of light, A (i.e., the backscattering coefficient), (2) reflections are modeled by ray optics, and (3) multiply scattered photons within a single voxel are negligible (see supplementary material). 25 Under these assumptions, the electric field observed in a given imaging voxel represents the sum of the reflections from N particles within the voxel, depicted in Figure 1 (a). These reflections can be treated as vectors of equal magnitude and random angle (phase). The angle h i between two vectors represents their difference in phase, and the OCT scattering intensity, X, detected from the two vectors can be analytically solved as a partial elliptical integral evaluated for all relative phase differences
Similarly, the mean vector for N scatterers can be computed by integrating N À 1 partial elliptical integrals that describe all inter-vector angles, which represent interference among the scatterers (often described as the sum of random phase vectors problem)
We used a Monte Carlo simulation to estimate the integral result (Eq. (S5), Figure S1 ), which led to the following model for the mean scattering electric field magnitude. In Spectral Domain OCT (SD-OCT), the cross-correlation term is used to assess the signal from the sample. This term (speckle intensity) is linear with the electric field. 19 The mean magnitude of speckle intensity, X, in a voxel as a function of N is
where A is the OCT intensity of a single particle. Interestingly, summing the random phase vectors is analogous to a 2D random walk 20 in which the length of the resulting mean vector is proportional to ffiffiffi ffi N p and A (Figure 1(b) ). As a note, the speckle pattern becomes more fully developed as N increases. However, we use the mean speckle intensity and thus do not require full Rayleigh distribution terms.
The number of scatterers, N, in a voxel follows a Poisson distribution with a mean of k, where k is the expected number of particles per voxel. Thus, the expected OCT intensity is
where the probability of having N ¼ k particles in a voxel is described by the Poisson distribution
Substituting (3) and (4b) into (4a) provides a full description of the mean OCT intensity observed from N scatterers per voxel
Eq. (5a) describes the expected speckle intensity from an ideal scatterer. However, real contrast agents such as GNRs are not ideal; these particles reflect varying amounts of light depending on their relative angular orientation to the incident beam, distance from the beam center, and other physical considerations. Despite these factors, we mathematically proved that any scatterer with a speckle intensity distribution function PðAÞ can be described as an ideal scatterer with an effective speckle intensity C 1 and effective number of particles per voxel C 2 , which are respectively defined as C 1 ¼ E½A 2 =E½A and C 2 ¼ E½A 2 =E 2 ½A (for the full proof, see supplementary material). 25 Using these definitions, Eq. (5a) can be rewritten as
Eq. (5b) generates a full model for scattering when multiplied by an exponential decay to account for light attenuation, as predicted by the Beer-Lambert Law (Eqs. (S17)-(S18)). Consequently, this model can describe nearly any sample that reflects light by adjusting the effective concentration and brightness (see supplementary material for further description and examples). 25 For low particle concentrations, k ( 1 and PðN ! 2Þ ( PðN ¼ 1Þ. In this case, the average speckle intensity is simply the average number of particles per voxel times the per particle intensity. When k ) 1, the Poisson distribution is a Gaussian distribution and the average speckle intensity is approximated as follows (see supplementary material for derivation): 25 
IðkÞ
Eq. (6) predicts two distinct regimes of signal increase with increasing particle concentration. Speckle intensity increases linearly with low concentrations. At higher concentrations, the speckle intensity increases as the square root of the number of scatterers due to inter-voxel interference. We calculated the transition between these phases, k crit ¼ 0:8 Â C 2 (Eq. (S15)). We tested our model against measured OCT signals from varying concentrations of GNRs in distilled deionized (DDI) water. GNRs (100 nm Â 30 nm, peak resonance ¼ 800 nm, Figure  S13 ) were synthesized using a method adapted from Ye et al. 21 and stabilized with poly(sodium-4-styrenesulfonate) (PSS, MW 70 kDa) as previously reported. 22 GNRs were prepared at concentrations ranging from 50 fM (2 Â 10 7 NPs/ml) to 5 nM (2 Â 10 12 NPs/ml) and then imaged in square-shaped glass capillary tubes (Figure 2(a) ) using a commercial spectral domain OCT system (Ganymede HR SD-OCT, ThorLabs, Newton, NJ). The SD-OCT light source was a superluminescent diode (SLD) with a center wavelength of 900 nm and a spectral bandwidth of 200 nm. The voxel size determined by the optical beam waist (x,y) and coherence length (z) was 8 lm Â 8 lm Â 2 lm (Full Width Half Max), and the SNR (Signal to Noise Ratio) was 106 dB. Figure 2(b) shows that below k crit ¼ 40 pM (which corresponded to $0.8 effective GNR per voxel), the increase in GNR OCT signal (red points) with concentration is roughly linear (black curve). However, the OCT signal measured from higher GNR concentrations increases by following a ffiffiffi ffi N p dependence (magenta curve). At sufficiently high concentrations, the observed OCT signal deviates even further from the ffiffiffi ffi N p prediction. This deviation occurs at the shadowing limit (dashed green vertical line)-the concentration of GNRs at which highest detectable signal is achieved near the top of the sample and deeper regions exhibits reduced or no signal due to photon attenuation. While linear square root models fit the data in certain concentration regimes, our model (depicted in blue) displays a highly correlated fit across all concentrations (R 2 ¼ 0.998). This model was calculated using Eq. (5b), where C 1 , C 2 , and (the extinction coefficient) were fit to the data using a least squares approximation. The best fit occurred for C 2 ¼ 3:9.
We further confirmed this result by showing that values of E½A and E½A 2 experimentally measured from low GNR concentrations were consistent with the C 1 and C 2 values obtained by fitting a large range of concentrations. This means that scattering intensity for high concentrations can be explained using data from low concentration tubes only (see supplementary material). 25 We next tested our model's ability to fit GNR signal in the presence of biological scattering environments. GNRs were prepared at various concentrations in freshly excised mouse blood. The final concentration of blood components in each sample was 90% of the original concentration in whole blood (for example, 10 ll of GNR solution and 90 ll of whole blood were mixed to produce the desired GNR concentration in 90% blood). OCT images were acquired as before (Figure 3(a) ). We were able to distinguish GNRs from blood at concentrations as low as 5 pM (p < 0.01), which corresponds to less than one effective GNR per voxel on average. We predicted (as described in the supplementary material) that the square root regime for GNRs in blood would exhibit the same C 1 and C 2 as GNRs in water. 25 As shown in Figure 3 (b), this prediction (blue line) accurately describes the experimental data (red points, R 2 ¼ 0.971). Interestingly, none of the measured signals from GNRs in blood fell within the linear regime. We attribute this to the strong interaction of light with blood, which creates multiple scattering trajectories (see supplementary material). 25 As a final demonstration, we fit the signals from known GNR concentrations acquired during intravenous injections into living nude (nu À /nu À ) mice (n ¼ 3). Each mouse was anesthetized with 2% isoflurane, and a total of 250 ll of 23.5 nM GNRs were tail-vein injected sequentially in 20 ll increments. After each incremental injection, GNRs were allowed to circulate for 1 min and an image of the right ear pinna (shown in Figure 4(a) ) was acquired. This process allowed us to measure the concentration-dependent OCT signal of GNRs in vivo. Figures 4(b)-4(c) show representative OCT images before and after incremental injections. As with in vitro experiments, we predicted that the same parameters and square root regime would provide a good prediction for in vivo data. Unlike the in vitro experiments, lighting conditions L (i.e., attenuation by tissue above the analyzed blood vessels) are unknown. Furthermore, light shadowing from high GNR concentration must also be considered by accounting for the vessel diameter D IðkÞ ¼ ½0:
where C 1 ; C 2 , and are taken from the fit for GNRs in water. k and c are GNR concentrations per voxel and in molarity, respectively. Both D and L should be fitted for each individual blood vessel (see Figure S18 for individual vessel plots). Eq. (7) fits the in vivo data well (R 2 ¼ 0.978), as shown in Figure 4(d) .
In summary, we describe a simple model for quantifying contrast-enhanced OCT signal based on the number of scattering agents within the imaging volume. Importantly, real particles can be described as ideal scatterers with modified speckle intensity and concentration. This model accurately describes experimental results for GNR contrast agents in water, blood, and in vivo. This model enables the extraction of quantitative measurements from OCT images provided only that expected speckle intensity can be estimated by averaging samples spatially or over time.
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